Mirum Pharmaceuticals, Inc. stock rating and score history
All changes in ratings, performance and outlook tracked over time.
Mirum Pharmaceuticals, Inc. stock price, chart patterns and momentum
Recent price movements, trend behaviour and momentum signals based on real-time market data.
What does Mirum Pharmaceuticals, Inc. do? Business model and key facts
Get the full picture of Mirum Pharmaceuticals, Inc.: what it builds, where it operates, and how it makes money.
Sector: Healthcare
Industry: Biotechnology
Employees (FY): 334
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It also develops Volixibat drug for treatment of intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Mirum Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Foster City, California.
Stocks related to Mirum Pharmaceuticals, Inc.
Selected based on industry alignment and relative market positioning.
Events and news impacting Mirum Pharmaceuticals, Inc. stock
Earnings, coporate decisions and industry developments that can affect the share price.
Mirum Pharmaceuticals, Inc. fundamentals and technical analysis
Financial fundamentals and technicals signals combined to access stability, momentum and market direction.
